The second test of its kind, Roche's nasal swab will be able to determine if the patient has COVID-19, Influenza A, Influenza Flu B or Respiratory Syncytial Virus during the span of a doctor's visit.

The second test of its kind, Roche's nasal swab will be able to determine if the patient has COVID-19, Influenza A, Influenza Flu B or Respiratory Syncytial Virus during the span of a doctor's visit.

Potentially harmful bacteria were found in the liquid buffer solution," Roche said in a statement. Some "Pilot COVID-19 At-Home Tests" are being recalled due to possible bacterial contamination.

ZURICH (Reuters) -Roche said on Friday it launched a laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients, as very high demand for tests prompts the ...

On March 12, 2020, Roche received FDA Emergency Use Authorization for the cobas® SARS-CoV-2 Test to detect the novel virus that causes COVID-19 disease. The test is also available in markets ...

Drugmaker Roche <ROG.S> has received emergency use authorisation from the U.S. Food and Drug Administration for its Elecsys IL-6 test to help identify severe inflammatory response in ...